1.97
price down icon1.01%   -0.02
after-market アフターアワーズ: 1.93 -0.04 -2.03%
loading
前日終値:
$1.99
開ける:
$1.95
24時間の取引高:
280.97K
Relative Volume:
1.05
時価総額:
$56.60M
収益:
$210.70K
当期純損益:
$-21.37M
株価収益率:
-1.7909
EPS:
-1.1
ネットキャッシュフロー:
$-21.10M
1週間 パフォーマンス:
+11.30%
1か月 パフォーマンス:
+11.30%
6か月 パフォーマンス:
+11.93%
1年 パフォーマンス:
+57.60%
1日の値動き範囲:
Value
$1.85
$2.02
1週間の範囲:
Value
$1.65
$2.044
52週間の値動き範囲:
Value
$0.89
$3.19

Gain Therapeutics Inc Stock (GANX) Company Profile

Name
名前
Gain Therapeutics Inc
Name
セクター
Healthcare (1174)
Name
電話
(301) 500-1556
Name
住所
4800 HAMPDEN LANE, BETHESDA
Name
職員
25
Name
Twitter
Name
次回の収益日
2025-03-26
Name
最新のSEC提出書
Name
GANX's Discussions on Twitter

GANX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
GANX
Gain Therapeutics Inc
1.97 56.60M 210.70K -21.37M -21.10M -1.10
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
441.30 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
521.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.83 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.14 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
241.20 28.51B 3.81B -644.79M -669.77M -6.24

Gain Therapeutics Inc Stock (GANX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-03-07 開始されました Scotiabank Sector Outperform
2024-12-06 開始されました ROTH MKM Buy
2024-08-14 再開されました Oppenheimer Outperform
2021-04-12 開始されました BTIG Research Buy
2021-04-12 開始されました Oppenheimer Outperform

Gain Therapeutics Inc (GANX) 最新ニュース

pulisher
Jun 18, 2025

Gene-Editing Stocks Gain on LLY-VERV Deal Announcement - TradingView

Jun 18, 2025
pulisher
Jun 16, 2025

SpringWorks Therapeutics (SWTX) Continues Strong Yearly Run, Showing Over 29% YTD Gain - Daily Chhattisgarh News

Jun 16, 2025
pulisher
Jun 15, 2025

Stellantis (NYSE:STLA) Receives Consensus Rating of “Hold” from Analysts - Defense World

Jun 15, 2025
pulisher
Jun 15, 2025

Gain Therapeutics, Inc. (NASDAQ:GANX) Given Consensus Rating of “Buy” by Analysts - Defense World

Jun 15, 2025
pulisher
Jun 15, 2025

Pharmaceutical Stocks Worth Watching – June 13th - Defense World

Jun 15, 2025
pulisher
Jun 13, 2025

Viking Therapeutics, Inc. (VKTX) Stock Drops Despite Market Gains: Important Facts to Note - MSN

Jun 13, 2025
pulisher
Jun 11, 2025

CRISPR Therapeutics Gains 14% in a Month: How to Play the Stock? - Yahoo Finance

Jun 11, 2025
pulisher
Jun 10, 2025

Gain Therapeutics to Participate in Upcoming Investor Conferences - Bluefield Daily Telegraph

Jun 10, 2025
pulisher
Jun 10, 2025

Gain Therapeutics Opens Access to Management: CEO Featured at Two Major Biotech Investor Conferences - Stock Titan

Jun 10, 2025
pulisher
Jun 08, 2025

Aquestive Therapeutics: Anaphylm Could Gain Significant Market Share (NASDAQ:AQST) - Seeking Alpha

Jun 08, 2025
pulisher
Jun 04, 2025

Telix Pharmaceuticals (ASX:TLX) Gains Portugal Approval for Illuccix in Prostate Cancer Detection - Yahoo Finance

Jun 04, 2025
pulisher
Jun 03, 2025

Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know - sharewise

Jun 03, 2025
pulisher
Jun 03, 2025

Northern Trust Corp Raises Holdings in Banco Bradesco S.A. (NYSE:BBDO) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Northern Trust Corp Invests $208,000 in Inhibikase Therapeutics, Inc. (NYSE:IKT) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Northern Trust Corp Has $226,000 Position in LightPath Technologies, Inc. (NASDAQ:LPTH) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Gain Therapeutics, Inc. (NASDAQ:GANX) Shares Purchased by Northern Trust Corp - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

i-80 Gold Corp. (NYSE:IAUX) Receives $3.50 Average PT from Brokerages - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Northern Trust Corp Increases Stock Holdings in PetMed Express, Inc. (NASDAQ:PETS) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Northern Trust Corp Purchases 10,466 Shares of United-Guardian, Inc. (NASDAQ:UG) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Northern Trust Corp Grows Stock Holdings in Bridger Aerospace Group Holdings, Inc. (NASDAQ:BAER) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Northern Trust Corp Increases Stock Position in NeueHealth, Inc. (NYSE:NEUE) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Pre-market Movers: LYRA, INM, OGEN, VERA... - RTTNews

Jun 02, 2025
pulisher
May 29, 2025

Lantern Pharma Inc. (LTRN)’s LP-184 Shows 345% Survival Gain in Rare Pediatric Brain Tumor Models - Yahoo Finance

May 29, 2025
pulisher
May 29, 2025

Gain Therapeutics Announces Oral Presentation at 2nd GBA1 Meeting - The Manila Times

May 29, 2025
pulisher
May 29, 2025

Gain Therapeutics, Inc. Announces Oral Presentation at GBA1 Meeting 2025 in Montreal - Nasdaq

May 29, 2025
pulisher
May 29, 2025

Gain Therapeutics' Chief Medical Officer Set to Reveal Latest GBA1 Therapeutic Developments in Montreal - Stock Titan

May 29, 2025
pulisher
May 28, 2025

Gain Therapeutics Files $100 Million Mixed Shelf - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

Gain Therapeutics (GANX) Pursues $100 Million Securities Offerin - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Gain Therapeutics (GANX) Pursues $100 Million Securities Offering | GANX Stock News - GuruFocus

May 28, 2025
pulisher
May 28, 2025

US Stocks Gain; Abercrombie & Fitch Posts Upbeat Earnings - Benzinga

May 28, 2025
pulisher
May 23, 2025

CytomX Therapeutics Inc’s (CTMX) 4.41% Gain Is A Reason To Reconsider. - Stocksregister

May 23, 2025
pulisher
May 22, 2025

HC Wainwright Brokers Increase Earnings Estimates for GANX - Defense World

May 22, 2025
pulisher
May 21, 2025

Gotham Asset Management LLC Sells 176,437 Shares of Gain Therapeutics, Inc. (NASDAQ:GANX) - Defense World

May 21, 2025
pulisher
May 21, 2025

Gain Therapeutics, Inc. (NASDAQ:GANX) Given Average Rating of “Buy” by Analysts - Defense World

May 21, 2025
pulisher
May 20, 2025

GM1 Gangliosidosis Market: Epidemiology, Therapies, - openPR.com

May 20, 2025
pulisher
May 20, 2025

Gain Therapeutics (NASDAQ:GANX) Receives Buy Rating from HC Wainwright - Defense World

May 20, 2025
pulisher
May 19, 2025

Gain Therapeutics (GANX) Maintains 'Buy' Rating with $8 Price Ta - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Roth Capital Predicts Reduced Earnings for Gain Therapeutics - Defense World

May 19, 2025
pulisher
May 15, 2025

Gain Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 15, 2025
pulisher
May 14, 2025

Gain Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 14, 2025
pulisher
May 14, 2025

Gain (GANX) Advances Parkinson's Treatment in Phase 1b Trials | - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Gain Therapeutics Reports Financial Results for First Quarter 2025 and Provides Corporate Update - The Manila Times

May 14, 2025
pulisher
May 14, 2025

Gain Therapeutics, Inc. Reports Q1 2025 Financial Results and Corporate Update, Highlights Progress in Parkinson’s Disease Drug Development - Nasdaq

May 14, 2025
pulisher
May 14, 2025

Gain Therapeutics' Parkinson's Drug Shows Promise: Key Biomarker Data Coming Mid-2025 - Stock Titan

May 14, 2025
pulisher
May 13, 2025

Zevra Therapeutics Q1 Net Loss Narrows, Revenue Rises; Shares Gain After Hours - marketscreener.com

May 13, 2025
pulisher
May 13, 2025

Crude Oil Gains 3%; US Inflation Eases In April - Benzinga

May 13, 2025
pulisher
May 12, 2025

Gain Therapeutics (GANX) Showcases Promising Parkinson's Treatme - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Gain Therapeutics, Inc. Presents New Evidence for GT-02287 as Potential Disease-Modifying Therapy for Parkinson’s Disease at IAPRD 30th World Congress - Nasdaq

May 12, 2025
pulisher
May 12, 2025

Gain Therapeutics Presents Preclinical Data at IAPRD 2025 30th World Congress on Parkinson's Disease and Related Disorders - The Manila Times

May 12, 2025
pulisher
May 12, 2025

Gain Therapeutics Presents Preclinical Data at IAPRD 2025 30th World Congress on Parkinson’s Disease and Related Disorders - TradingView

May 12, 2025
pulisher
May 11, 2025

Gain Therapeutics (GANX) Expected to Announce Earnings on Tuesday - Defense World

May 11, 2025

Gain Therapeutics Inc (GANX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Gain Therapeutics Inc (GANX) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Islam Khalid
Executive Chairman
Aug 09 '24
Buy
1.00
50,000
49,940
50,000
RICHMAN ERIC I
Director
Jul 01 '24
Buy
1.22
17,000
20,670
289,629
$20.50
price down icon 1.11%
$35.87
price up icon 1.70%
$20.60
price down icon 3.38%
$99.49
price down icon 2.21%
$106.72
price up icon 0.55%
biotechnology ONC
$241.20
price down icon 5.22%
大文字化:     |  ボリューム (24 時間):